Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

Investor logo

Warning

This publication doesn't include Faculty of Sports Studies. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

MOYSIADIS T. BALIAKAS P. ROSSI D. CATHERWOOD M. STREFFORD J.C. DELGADO J. ANAGNOSTOPOULOS A. BELESSI C. STAVROYIANNI N. POSPÍŠILOVÁ Šárka OSCIER D. GAIDANO G. CAMPO E. ROSENQUIST R. GHIA P. STAMATOPOULOS K.

Year of publication 2019
Type Article in Periodical
Magazine / Source Leukemia
MU Faculty or unit

Central European Institute of Technology

Citation
Web https://www.nature.com/articles/s41375-018-0322-7
Doi http://dx.doi.org/10.1038/s41375-018-0322-7
Keywords SURVIVAL
Attached files
Description Chronic lymphocytic leukemia (CLL) displays remarkable clinical heterogeneity, likely attributed to the underlying biological diversity. This claim is supported by the fact that certain immunogenetic and/or genomic features identify subgroups of CLL patients with distinct prognosis and outcome.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info